Clinical Trial Update: Immune Non-inferiority and Safety of a Vi-DT Typhoid Conjugate Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing immune non-inferiority and safety of a Vi-DT typhoid conjugate vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Typhoid

Drugs mentioned

• Vi-DT Typhoid Conjugate Vaccine (Vi-diphtheria toxoid conjugate vaccine)

Snippet

Sponsor: International Vaccine Institute | Conditions: Typhoid | Phase 3 | Status: UNKNOWN